The United States of America has become the first country to authorize the usage of COVID-19 vaccine to children between the age group 1215 years. The USFDA has allowed administering the COVID-19 vaccine PfizerBioNTech for emergency use to adolescents. The US President has instructed the states to make immediate arrangements for vaccine availability for adolescents. Being one of the worst hit countries with the pandemic with a record infections to over 3.27 crore infections including 5.81 lakh deaths, the US allowed Pfizer’s vaccine. Currently, around 2 million people in that group have already received at least one shot. With the trial results announced by Pfizer on adolescents indicating that the vaccine is effective in that age group, it becomes necessary to raise the immunity in the population and bring down the number of hospitalizations and deaths.
The expansion is a major development in the USA’s vaccine campaign and comes at the right time when parents are worried to protect their children during summer activities and before the start of new school session. Pfizer’s vaccine is being used in multiple countries for teens as young as 16, and Canada recently became the first to expand use to 12 and up.